HSPA5 and cancer: We propose that the clinical outcomes in cancer may be controlled and also identified through changes in the cell-surface GRP78 expression in different cell subpopulations and the resulting effect on invasiveness; those can produce phenotypes with varying invasiveness and change the overall invasiveness of the sample.